Other
Bone Loss
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Bone Loss is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed8 · 67%
Unknown status2 · 17%
Recruiting1 · 8%
Not yet recruiting1 · 8%
Clinical Trials
Trial Activity
12 trials
Simvastatin to Prevent SCI-Induced Bone Loss
Unknown status·—·Phase 2·NCT02946424·76 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)